PrimeRFP SCOUT · Federal Contract Recompete Brief

SPE2D020D00044610053608! — Bayer Healthcare Pharmaceuticals Inc

Bayer Healthcare Pharmaceuticals Inc holds $14.3M across 87 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards in the incumbent pipeline. Set-aside status: NONE.

Dla Troop Support
Awarding office
Bayer Healthcare Pharmaceuticals Inc
Recipient
Estimated value
6505
PSC
NONE
Set-aside

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Bayer Healthcare Pharmaceuticals Inc — $90

Contract facts

NONE
Contract numberSPE2D020D0004
Also listed asSPE2D0-20-D-0004
AgencyDla Troop Support
Awarding officeDla Troop Support
Awarding agencyDepartment of Defense (DOD)
Funding agencyDepartment of Defense (DOD)
IncumbentBayer Healthcare Pharmaceuticals Inc
UEIV1EVGCK7XES8
PSC6505
Related solicitationSPE2D015R0002

4610053608! is a federal NONE award for Dla Troop Support held by Bayer Healthcare Pharmaceuticals Inc. Estimated value —. Related solicitation SPE2D015R0002.

Incumbent footprint

Public record

Bayer Healthcare Pharmaceuticals Inc$14.3M obligated across 87 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($14.3M) · all agencies
Department of Health and Human Services (HHS)$15.1M · 106%Department of Defense (DOD)$387K · 3%Department of Justice (DOJ)$345K · 2%
Open full company profile

Related awards

Same incumbent
75A50325F80035
PURCHASE CIPROFLOXACIN 250MG/5ML ORAL SUSPENSION, POWDER, 100ML BOTTLE
$15.1M
Sep 29, 2026
36C26226F0163
XOFIGO - RADIUM RA 223DICHLORIDE INJ
$181K
Mar 31, 2027
SPE2D026F0101
8511938413!OTHER MEDICAL
$120K
Apr 5, 2027
36C25626N0492
XOFIGO RADIUM 223 FOR CANCER TREATMENT.
$387K
Apr 9, 2027
36C24723F0573
RA-223 DICHLORIDE XOFIGO RADIO PHARM
$264K
Jun 30, 2028

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract SPE2D020D0004?

SPE2D020D0004 (4610053608!) is a Dla Troop Support award with an estimated value of —, currently held by Bayer Healthcare Pharmaceuticals Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is SPE2D0-20-D-0004?

SPE2D0-20-D-0004 is the dashed form of PIID SPE2D020D0004 (4610053608!), held by Bayer Healthcare Pharmaceuticals Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded SPE2D020D0004?

Dla Troop Support awarded SPE2D020D0004 to Bayer Healthcare Pharmaceuticals Inc.

Who is the incumbent on SPE2D020D0004?

Bayer Healthcare Pharmaceuticals Inc is the incumbent with $14.3M across 87 related awards in SCOUT’s public footprint.

When does Bayer Healthcare Pharmaceuticals Inc’s SPE2D020D0004 come up for recompete?

SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthly
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/SPE2D020D0004